Bronchial carcinoma. VI. Some aspects of the therapy of inoperable patients.
In small cell anaplastic carcinoma with localized disease the median survival for radiotherapy, single drug chemotherapy or operation was 10.1 months. The median survival for radiotherapy or single drug chemotherapy for small cell anaplastic carcinoma with extensive disease was 2.8 months and for untreated controls 0.5 months. The difference in the quality of survival was moderate, 2.0 vitagram points per month. Untreated epidermoid carcinoma patients with localized disease had a median survival of 11.4 months, which is the level reached by most non-surgical therapeutic regimes today.
D000328:Adult; D000368:Aged; D001984:Bronchial Neoplasms / Q000188:drug therapy / Q000401:mortality* / Q000532:radiotherapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011379:Prognosis; D011788:Quality of Life
D010919:Placebos; D003520:Cyclophosphamide